Camlin Fine Sciences Limited has informed the Exchange about press release issued by the Company.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences has filed a draft tender offer with the French Stock Markets Authority (AMF) for the remaining shares of Vinpai, a French company listed on Euronext Growth Paris. CFSL acquired a majority stake of 78.68% in Vinpai in November 2025 and now holds 83.82% of share capital after converting convertible bonds. The tender offer targets the remaining 16.18% shares at EUR 3.60 per share, the same price as the original block acquisition. Vinpai's Board of Directors has unanimously issued a favorable opinion on the offer, supported by a fairness opinion from independent expert Crowe HAF. CFSL has clarified it does not intend to implement a squeeze-out procedure.
The tender offer gives minority shareholders of Vinpai an opportunity to exit at the same price as the block acquisition, providing immediate liquidity. For CFSL shareholders, this strengthens control over Vinpai without any immediate material impact on financials.